Sitemap

About Us

• About Alkem
• Our Values
• Board of Directors
• Leadership Team
• Code of Ethics
• Milestones
• Awards & Achievements
• Founder Story

Offerings

• Therapies

  • Oncology
  • Anti - Infective
  • Anti-Osteoporosis
  • Cardiology
  • Dermatology
  • Diabetology
  • Gynaecology
  • Ophthalmology
  • Respiratory
  • Rheumatology
  • Urology
  • Gastroenterology
  • Neurology
• Rx Products
• Alkem Generic

International Presence

• Europe

  • Germany
  • UK

• Latin America

  • Chile
  • Colombia
• US
• Australia
• Overview

• Emerging Market

  • Kazakhstan
  • Philippines
  • UAE
  • East Africa
  • French West Africa
  • South Africa
  • Francophone

Capabilities

• R&D

  • Capabilities
  • Achievements
  • Research Facilities
• Manufacturing Facilities
• Quality
• Facility Tour

Responsibility

• ESG

• CSR

  • Thematic Areas
  • Benificiary Corner
  • Employee Volunteering
  • Recognitions and Awards
  • CSR Annual Report
  • CSR Action Plan
  • Alkem Foundation

Investors

• Financial Overview
• Disclosure on Related Party Transaction
• Forms
• Dividend Details

• Disclosure under Regulation 46 of LODR

  • Composition of Committees
  • Policies
  • Shareholding Pattern
  • Annual Reports
  • Quaterly Reports
  • Notice of Board Meeting
  • Annual Returns
  • Subsidiary Financial Statements
  • Details of Business
  • Credit Rating
  • Secreterial Compliance Report
  • Newspaper Advertisements
  • Investor/Analyst Meet
  • Disclosure Under Regulations 30
  • Familiarization Programme
  • Contact Details

Careers

• Life at Alkem
• Culture at Alkem
• Employee Value Proposition
• Work with Us
• Happy Alkemites
• Experienced - Early Careers

Media Room

• Corporate Press Kit
• News Updates
• Press Release

Quick Links

• Alkem Activa
• Ascend Laboratories
• Cachet
• Enzene
• Indchemie
• Norac Pharma

Contact Us

• Adverse Event Reporting
• Partnership
• Key Contacts